Even at the beginning of the COVID-19 pandemic, a group of scientists from the Institute of Cell Therapy set themselves the goal of learning the details of the course of this disease.
Their research combined analysis of clinical and laboratory data of patients who were hospitalized at 7, 14, and 28 days of observation with findings from computed tomography. This made it possible to identify prognostic factors for disease severity within 48 weeks after the onset of symptoms. All this contributed to a detailed description of the course of the disease.
The authors of the study, which was published in the journal “Biomedical Reports” (March 2023, Biomedical Reports 18 (5) DOI: 10.3892 / br.2023.1615), investigated the dynamics of changes in immune cells, specific markers of the inflammatory process in the blood of patients with a severe course. from COVID-19 and develop acute respiratory distress syndrome (ARDS), a life-threatening lung injury caused by coronavirus infection.
Monitoring the dynamics of changes in the immune cells of patients infected with COVID-19 at different stages of treatment can be useful for predicting disease progression and the body’s response to treatment in severe patients with COVID-19 and ARDS.
Scientists at the Institute of Cell Therapy suggest that immune cells from a patient’s blood can be used as markers for COVID-19, which should help the global medical community fight the pandemic coronavirus infection.
Link to the publication “Biomedical Reports” https://www.spandidos-publications.com/10.3892/br.2023.1615
